Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/28/23
End: 05/31/26
Due: 05/31/27
Phase: N/A
Priority: Normal
Start: 01/15/25
End: 07/30/27
Due: 07/30/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc) | NCT06114004 | Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas | user2@example.com | None | 2023-09-28 | 2026-05-31 | 2027-05-31 | - | - | 2025-07-14 |
| Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas | NCT07032285 | Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas | user2@example.com | None | 2025-01-15 | 2027-07-30 | 2028-07-30 | - | - | 2025-07-14 |